Equate Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 79903-419

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Equate Esomeprazole Magnesium (NDC 79903-419). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Walmart Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Equate-esomeprazole-magnesium-mint-carton-image-1.jpg (Equate Esomeprazole Magnesium Mint Carton Image 1)

Equate-esomeprazole-magnesium-mint-carton-image-1.jpg (Equate Esomeprazole Magnesium Mint Carton Image 1)
This product contains three bottles of Equate active flavored capsules of Esomeprazole Magnesium Delayed-Release Capsules, 20 mg. It is an acid reducer that treats frequent heartburn with a cool mint 24HR flavor. The capsules release a cooling sensation in the mouth and throat. It offers a 14-day course of treatment with three bottles for full effectiveness, with results possibly seen in 1 to 4 days.*
FDA Label Image

Equate-esomeprazole-magnesium-mint-carton-image-2.jpg (Equate Esomeprazole Magnesium Mint Carton Image 2)

Equate-esomeprazole-magnesium-mint-carton-image-2.jpg (Equate Esomeprazole Magnesium Mint Carton Image 2)
The text contains instructions, warnings, and drug facts for a product related to heartburn. It provides details on usage, dosage, side effects, and precautions to be taken. It advises against using the product in certain medical conditions and recommends consulting a doctor before use. It also includes tips for managing heartburn and information on inactive ingredients. The product is clinically proven to treat frequent heartburn. Additionally, it indicates that it is not manufactured or distributed by AstraZeneca AB Corporation, which owns the registered trademark "Nexium".*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.